ReShape Lifesciences Inc (RSLS)

[ALERTS100%to10000%GAIN]

RSLS~~will go 200% next week

SAN CLEMENTE, Calif., June 7, 2018 /PRNewswire/ -- ReShape Lifesciences Inc. (RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that it has entered into definitive agreements with several institutional investors for the purchase of 374,572 shares of its common stock, at a purchase price per share of $3.92, for gross proceeds of approximately $1.47 million, in a registered direct offering priced at-the-market. Additionally, ReShape Lifesciences has also agreed to issue to the investors unregistered warrants to purchase up to 280,929 shares of common stock, at a purchase price per warrant of $0.125, for gross proceeds of approximately $0.03 million. The warrants have an exercise price of $3.93 per share of common stock, will be exercisable immediately and will expire five and one-half years from the issuance date.